Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × Oxycodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 3 Neoplasms 3 Trigger Finger Disorder 1 Nutrition Disorders 1 Neuralgia 1 Nasopharyngeal Carcinoma 1 Kidney Neoplasms 1 Intra-abdominal Cancer 1 Ganglion Cysts 1 Dupuytren Contracture 1 De Quervain Disease 1 Constipation 1 Carpal Tunnel Syndrome 1 Cancer Pain 1 Bronchiolitis Obliterans Syndrome 1

Interventions

aldesleukin 18 Sunitinib 18 Interferon-alpha 13 Bevacizumab 13 Interleukin-2 12 Cyclophosphamide 12 Gemcitabine 11 Everolimus 11 fludarabine phosphate 10 Sorafenib 8 Peripheral Blood Stem Cell Transplantation 8 Axitinib 8 Nivolumab 7 Ipilimumab 6 sargramostim 5 pembrolizumab 5 Filgrastim 5 Doxorubicin 5 Carboplatin 5 Capecitabine 5 cabozantinib 4 Thalidomide 4 Tacrolimus 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Bortezomib 4 temsirolimus 3 fludarabine 3 Radiotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡